- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04174248
Breast Cancer Self-Management Mobile Care Application Intervention in the Quality of Life
November 20, 2019 updated by: I-Ching Hou, National Yang Ming University
The Evaluation of Intelligence Breast Cancer Self-Management Mobile Care Application Intervention in the Quality of Life for Newly Diagnosed Non-metastatic Breast Cancer Women: Randomized Controlled Trial.
The aim of this study was to investigate the quality of life (QoL) for women with breast cancer in Taiwan after using the BCSMS App.
Study Overview
Detailed Description
After receiving their first diagnosis of breast cancer, women with stage 0 to III were randomized into intervention and control groups.
Intervention group subjects used BCSMS App and the control group subjects received usual care.
Two questionnaires: EORTC QLQ-C30 and EORTC QLQ-BR 23 were distributed to subjects in both arms at baseline and at 1.5 and 3 months.
All evaluations were anonymous.
Study Type
Interventional
Enrollment (Actual)
112
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 11221
- National Yang-Ming University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- first diagnosis of breast cancer with stage 0 to III in past year.
- aged 20 to 65 years
- had an Android/iOS smartphone;
- able to read and write in Chinese;
- willing to participate in the study and provide informed consent.
Exclusion Criteria:
- not matched to inclusion criteria
- mental illness
- serious illness and life-threatening
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental group
Experimental group with BCSMS App using
|
Breast Cancer Using a Self-Management Support mHealth Application
|
No Intervention: Control group
Control group without BCSMS App using
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Baseline EORTC QLQ-C30
Time Frame: Baseline
|
Baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3).
The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
|
Baseline
|
Change of EORTC QLQ-C30 at 1.5 month
Time Frame: 1.5 month
|
Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3) to 1.5 month.The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
|
1.5 month
|
Change of EORTC QLQ-C30 at 3 month
Time Frame: the 3rd month
|
Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Core 30 (version 3) to the 3rd month.
The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
|
the 3rd month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Baseline EORTC QLQ-BR23
Time Frame: Baseline
|
Baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Breast 23 (version 3).
The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
|
Baseline
|
Change of EORTC QLQ-BR23 at 1.5 month
Time Frame: 1.5 month
|
Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Breast 23 (version 3) to 1.5 month.
The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
|
1.5 month
|
Change of EORTC QLQ-BR23 at 3 month
Time Frame: the 3rd month
|
Change from baseline Taiwan Chinese version of the European Organisation for Research and Treatment of Cancer Quality of Life -Breast 23 (version 3) to the 3rd month.
The minimum and maximum values are 0 and 100, and higher scores mean a better outcome.
|
the 3rd month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: ICing Hou, PhD, National Yang Ming University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 11, 2019
Primary Completion (Actual)
July 6, 2019
Study Completion (Actual)
July 6, 2019
Study Registration Dates
First Submitted
November 19, 2019
First Submitted That Met QC Criteria
November 20, 2019
First Posted (Actual)
November 22, 2019
Study Record Updates
Last Update Posted (Actual)
November 22, 2019
Last Update Submitted That Met QC Criteria
November 20, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YM107109E
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on BCSMS App
-
University of VictoriaRecruiting
-
Hypnalgesics, LLCTufts UniversityCompletedDental Anxiety | Opioid Use | Drug Use | Dental PainUnited States
-
Barbara Ann Karmanos Cancer InstituteCompletedCancer | Financial Toxicity | Question Prompt ListUnited States
-
University of California, San FranciscoConquer Cancer FoundationActive, not recruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Big Health Inc.National Institute of Mental Health (NIMH); Duke UniversityActive, not recruiting
-
Chang Gung UniversityChang Gung Memorial HospitalRecruiting
-
University Hospitals Cleveland Medical CenterNot yet recruiting
-
University of Sao PauloNot yet recruitingPostpartum Depression
-
Florida Atlantic UniversityActive, not recruitingHealth BehaviorUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Completed